<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on two patients with a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> in whom the blood cell counts markedly improved during treatment with haem arginate </plain></SENT>
<SENT sid="1" pm="."><plain>One patient received haem arginate only, the other haem arginate in combination with low dose <z:chebi fb="3" ids="50113">androgen</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The drug was given as weekly infusions of 2-3 mg/kg body weight for 8-12 weeks </plain></SENT>
<SENT sid="3" pm="."><plain>In one patient the percentage of ringed and other abnormal sideroblasts in the bone marrow was clearly reduced as a result of the treatment </plain></SENT>
<SENT sid="4" pm="."><plain>In both patients the effect on blood cell counts lasted for several months after the cessation of the haem arginate treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Eleven other patients showed no clear response </plain></SENT>
<SENT sid="6" pm="."><plain>No adverse effects of the infusions were observed </plain></SENT>
<SENT sid="7" pm="."><plain>Further studies on the possible therapeutic role of haem arginate are indicated </plain></SENT>
</text></document>